Novacyt S.A. (ALNOV.PA)

EUR 0.45

(-2.68%)

Gross Profit Summary of Novacyt S.A.

  • Novacyt S.A.'s latest annual gross profit in 2023 was 3.73 Million GBP , down -35.09% from previous year.
  • Novacyt S.A.'s latest quarterly gross profit in 2023 FY was 3.73 Million GBP , down -35.09% from previous quarter.
  • Novacyt S.A. reported a annual gross profit of 5.74 Million GBP in annual gross profit 2022, down -80.64% from previous year.
  • Novacyt S.A. reported a annual gross profit of 29.67 Million GBP in annual gross profit 2021, down -85.94% from previous year.
  • Novacyt S.A. reported a quarterly gross profit of 946.81 Thousand GBP for 2023 Q1, up 22.79% from previous quarter.
  • Novacyt S.A. reported a quarterly gross profit of 968.85 Thousand GBP for 2023 Q2, up 2.33% from previous quarter.

Annual Gross Profit Chart of Novacyt S.A. (2023 - 2011)

Historical Annual Gross Profit of Novacyt S.A. (2023 - 2011)

Year Gross Profit Gross Profit Growth
2023 3.73 Million GBP -35.09%
2022 5.74 Million GBP -80.64%
2021 29.67 Million GBP -85.94%
2020 211.12 Million GBP 2851.8%
2019 7.15 Million EUR -7.8%
2018 7.75 Million EUR -2.08%
2017 7.92 Million EUR 52.86%
2016 5.18 Million EUR 64.28%
2015 3.15 Million EUR 1625.68%
2014 182.81 Thousand EUR 218.07%
2013 -154.84 Thousand EUR -194.0%
2012 164.73 Thousand EUR 197.19%
2011 55.42 Thousand EUR 0.0%

Peer Gross Profit Comparison of Novacyt S.A.

Name Gross Profit Gross Profit Difference
Affluent Medical SA -1.2 Million EUR 410.833%
Bluelinea Société Anonyme -3.84 Million EUR 196.944%
Carmat SA -30.97 Million EUR 112.044%
Diagnostic Medical Systems S.A. 15.84 Million EUR 76.456%
Euromedis Groupe 3.57 Million EUR -4.436%
Eurobio Scientific Société anonyme 53.96 Million EUR 93.088%
Ikonisys S.A. 255.82 Thousand EUR -1358.017%
Implanet S.A. 3.13 Million EUR -19.093%
Median Technologies SA -2.55 Million EUR 246.217%
SpineGuard SA 3.37 Million EUR -10.386%
Theraclion SA -1.08 Million EUR 445.247%
Euroapi S.A. 164.6 Million EUR 97.734%
Guerbet SA 197.14 Million EUR 98.108%